Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SH) has announced that it recently obtained a Medical Device Registration Certificate (for in vitro diagnostic reagents) issued by the National Medical Products Administration. The product, named Influenza A H1N1 (2009) and Seasonal H3 Subtype Nucleic Acid Detection Kit (Fluorescent PCR Method), is intended for the qualitative detection of nucleic acids from Influenza A H1N1 (2009) and seasonal H3 subtype viruses in human throat swab samples.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.